Not Yet RecruitingPhase 2

Amino Acids for Cardiac Surgery Associated AKI

United States30 participantsStarted 2025-09

Plain-language summary

The purpose of this study is to assess the feasibility of amino acid infusions in pediatric cardiac surgery patients.

Who can participate

Age range1 Day – 18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Undergoing cardiac surgery and expected to be high risk Exclusion Criteria: * preoperative extracorporeal organ support * CKD history (GFR\<60ml/min/1.73m2 \[≤1year\] and GFR\<90ml/min/1.73m2 \[\>1 year\]) * serum creatinine defined preoperative AKI.

What they're measuring

Number of Participants with Amino acids Related Adverse Events

Timeframe: Baseline, Daily during infusion upto 48 hours after completion of infusion (upto 5 days)

Trial details

NCT IDNCT07001098

SponsorStanford University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-11

View on ClinicalTrials.gov More Acute Kidney Injury trials